Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain
Stopped early · Phase 2
Conditions studied: Kidney Cancer, Melanoma (Skin), Metastatic Cancer, Ovarian Cancer, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well conformal radiation therapy works in treating patients with metastatic cancer outside the brain.
Key facts
- Study ID
- NCT00550654
- Run by
- National Institutes of Health Clinical Center (CC)
- People needed
- 1
- Starts
- 2007-10-01
- Expected to finish
- 2010-05-01
- Last updated by the study team
- 2017-01-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.